Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia

Journal of the Peripheral Nervous System

Volumn 20, Issue 1, 2015, Pages 37-46

  Lavoie Smith, Ellen M ^a   Li, Lang ^b   Chiang, Chienwei ^b   Thomas, Karin ^c   Hutchinson, Raymond J ^a   Wells, Elizabeth M ^d   Ho, Richard H ^e   Skiles, Jodi ^b   Chakraborty, Arindom ^b   Bridges, Celia M ^a   Renbarger, Jamie ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b INDIANA UNIVERSITY   (United States)

^c CHILDREN S HOSPITAL COLORADO   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

acute lymphoblastic leukemia; children; patterns; severity; vincristine induced peripheral neuropathy

Indexed keywords

VINCRISTINE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ADVERSE OUTCOME; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DRUG SAFETY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOTOR NEUROPATHY; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SENSORY NEUROPATHY; CHEMICALLY INDUCED; INFANT; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SEVERITY OF ILLNESS INDEX; VINCRISTINE;

EID: 84930977269     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/jns.12114     Document Type: Article

References (38)

1. American Cancer Society (2013). Childhood leukemia. http://www.cancer.org. Updated 2013. Accessed October 25, 2013.
2. American Cancer Society (2014). Cancer Facts & Figures 2014. http://www.cancer.org. Accessed February 26, 2015.
3. Anghelescu DL, Faughnan LG, Jeha S, Relling MV, Hinds PS, Sandlund JT, Cheng C, Pei D, Hankins G, Pauley JL, Pui C, (2011). Neuropathic pain during treatment for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 57: 1147-1153.
4. Argyriou AA, Bruna J, Marmiroli P, Cavaletti G, (2012). Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol 82: 51-77.
5. Bisogno G, Ferrari A, Bergeron C, Scagnellato A, Prete A, Alaggio R, Casanova M, D'Angelo P, Di Cataldo A, Carli M, (2005). The IVADo regimen-a pilot study with ifosfamide, vincristine, actinomycin D, and doxorubicin in children with metastatic soft tissue sarcoma: a pilot study of behalf of the European Pediatric Soft Tissue Sarcoma Study Grou. Cancer 103: 1719-1724.
6. Bosenberg A, Thomas J, Lopez T, Kokinsky E, Larsson LE, (2003). Validation of a six- graded faces scale for evaluation of postoperative pain in children. Paediatr Anaesth 13: 708- 713.
7. Cavaletti G, Frigeni B, Lanzani F, Mattavelli L, Susani E, Alberti P, Cortinovis D, Bidoli P, (2010). Chemotherapy-induced peripheral neurotoxicity assessment: a critical revision of the currently available tools. Eur J Cancer 46: 479-494.
8. Cavaletti G, Cornblath DR, Merkies IS, Postma TJ, Rossi E, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galie E, Briani C, Dalla Torre C, Faber CG, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Valsecchi MG, CI-PeriNomS Group (2013). The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Ann Oncol 24: 454-462.
9. Chauvenet AR, Shashi V, Selsky C, Morgan E, Kurtzberg J, Bell B, Pediatric Oncology Group S (2003). Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Pediatr Hematol Oncol 25: 316-320.
10. Cornblath DR, Chaudhry V, Carter K, Lee D, Seysedadr M, Miernicki M, Joh T, (1999). Total neuropathy score: validation and reliability study. Neurology 53: 1660-1664.
11. Dennison JB, Kulanthaivel P, Barbuch RJ, Renbarger JL, Ehlhardt WJ, Hall SD, (2006). Selective metabolism of vincristine in vitro by CYP3A5. Drug Metab Dispos 34: 1317-1327.
12. Diouf B, Crews KR, Lew G, Pei D, Cheng C, Bao J, Zheng JJ, Yang W, Fan Y, Wheeler HE, Wing C, Delaney SM, Komatsu M, Paugh SW, McCorkle JR, Lu X, Winick NJ, Carroll WL, Loh ML, Hunger SP, Devidas M, Pui CH, Dolan ME, Relling MV, Evans WE, (2015). Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia. JAMA 313: 815-823.
13. Egbelakin A, Ferguson M, MacGill E, Lehmann A, Topletz A, Quinney S, Li L, McCammack K, Hall S, Renbarger J, (2011). Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 56: 361-367.
14. Frigeni B, Piatti M, Lanzani F, Alberti P, Villa P, Zanna C, Ceracchi M, Ildebrando M, Cavaletti G, (2011). Chemotherapy-induced peripheral neurotoxicity can be misdiagnosed by the National Cancer Institute Common Toxicity Scale. J Peripher Nerv Syst 16: 228-236.
15. Gilchrist L, (2012). Chemotherapy-induced peripheral neuropathy in pediatric cancer patients. Semin Pediatr Neurol 19: 9-17.
16. Gilchrist LS, Tanner L, (2013). The pediatric-modified Total Neuropathy Score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers. Support Care Cancer 21: 847-856.
17. Gilchrist LS, Marais L, Tanner L, (2014). Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children. Support Care Cancer 22: 359-366.
18. Gomber S, Dewan P, Chhonker D, (2010). Vincristine induced neurotoxicity in cancer patients. Indian J Pediatr 77: 97-100.
19. Griffith K, Merkies ISJ, Hill E, Cornblath D, (2010). Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties. J Peripher Nerv Syst 15: 314-325.
20. Hockenberry MJ, (Ed) (2005). Wong's Essentials of Pediatric Nursing, 7th Edn. Elsevier Mosby, St. Louis, pp 1307.
21. Hoffman MC, Mulrooney DA, Steinberger J, Lee J, Baker KS, Ness KK, (2013). Deficits in physical function among young childhood cancer survivors. J Clin Oncol 31: 2799-2805.
22. Kaufman L, Rousseeuw P, (1987). Clustering by Means of Medoids, Vol. 3. Faculty of Mathematics and Informatics, Delft University of Technology.
23. Khan RB, Hudson MM, Ledet DS, Morris EB, Pui CH, Howard SC, Krull KR, Hinds PS, Crom D, Browne E, Zhu L, Rai S, Srivastava D, Ness KK, (2014). Neurologic morbidity and quality of life in survivors of childhood acute lymphoblastic leukemia: a prospective cross-sectional study. J Cancer Surviv 8: 688-96.
24. Kortmann RD, Kuhl J, Timmermann B, Mittler U, Urban C, Budach V, Richter E, Willich N, Flentje M, Berthold F, Slavc I, Wolff J, Meisner C, Wiestler O, Sorensen N, Warmuth-Metz M, Bamberg M, (2000). Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 46: 269-279.
25. Kumar N, (2007). Nutritional neuropathies. Neurol Clin 25: 209-255.
26. Liew E, Thyagu S, Atenafu EG, Alibhai SM, Brandwein JM, (2013). Quality of life following completion of treatment for adult acute lymphoblastic leukemia with a pediatric-based protocol. Leuk Res 37: 1632-1635.
27. Messinger Y, Gaynon P, Raetz E, Hutchinson R, Dubois S, Glade-Bender J, Sposto R, van der Giessen J, Eckroth E, Bostrom BC, (2010). Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): a report from the Therapeutic Advances in Childhood Leukemia (TACL) Consortium. Pediatr Blood Cancer 55: 254-259.
28. Messinger YH, Gaynon PS, Sposto R, van der Giessen J, Eckroth E, Malvar J, Bostrom BC, Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium (2012). Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) study. Blood 120: 285-290.
29. Ness KK, Jones KE, Smith WA, Spunt SL, Wilson CL, Armstrong GT, Srivastava DK, Robison LL, Hudson MM, Gurney JG, (2013). Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St Jude Lifetime Cohort study. Arch Phys Med Rehabil 94: 1451-1457.
30. Paice JA, (2009). Clinical challenges: chemotherapy-induced peripheral neuropathy. Semin Oncol Nurs 25: S8-S19.
31. Postma TJ, Benard BA, Huijgens PC, Ossenkoppele GJ, Heimans JJ, (1993). Long-term effects of vincristine on the peripheral nervous system. J Neurooncol 15: 23-27.
32. Postma TJ, Heimans JJ, Muller MJ, Ossenkoppele GJ, Vermorken JB, Aaronson NK, (1998). Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy. Ann Oncol 9: 739- 744.
33. Ramchandren S, Leonard M, Mody RJ, Donohue JE, Moyer J, Hutchinson R, Gurney JG, (2009). Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. J Peripher Nerv Syst 14: 184-189.
34. Smith EL, Beck SL, Cohen J, (2008). The total neuropathy score (TNS): a tool for measuring chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum 35: 96-102.
35. Smith EM, Li L, Hutchinson RJ, Ho R, Burnette WB, Wells E, Bridges C, Renbarger J, (2013). Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. Cancer Nurs 6: E49-60.
36. Toopchizadeh V, Barzegar M, Rezamand A, Feiz AH, (2009). Electrophysiological consequences of vincristine contained chemotherapy in children: a cohort study. J Pediatr Neurol 7: 351-356.
37. Vats T, Buchanan G, Mehta P, Ragab A, Hvizdale E, Nitschke R, Link M, Beardsley GP, Maybee D, Krischer J, (1992). A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study. Invest New Drugs 10: 231-234.
38. Verstappen CC, Koeppen S, Heimans JJ, Huijgens PC, Scheulen ME, Strumberg D, Kiburg B, Postma TJ, (2005). Dose-related vincristine-induced peripheral neuropathy with unexpected off- therapy worsening. Neurology 64: 1076-1077.